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21
An intact immune response is critical for survival of hosts chronically infected with
22
Toxoplasma gondii. We observe clusters of macrophages surrounding replicating parasite in brain 23 tissue, but the initial cues which instruct focal inflammatory reactions in the central nervous 24 system (CNS) are not well understood. One potential mechanism of broad relevance is host cell 25 damage. Here we find that IL-33, a nuclear alarmin, is critical for control of T. gondii parasites in 
INTRODUCTION 38 39
Toxoplasma gondii is a eukaryotic parasite which encysts in the brain parenchyma of its 40 hosts, including humans and mice [1] [2] [3] . Mortality from T. gondii infection is associated with , HIV-AIDS patients [5] [6] [7] , and in congenital infection 
50
at limiting parasite replication via direct toxicity and depletion of arginine in vitro 2, 12 . iNOS is also 51 vital to survival of chronic brain infection in vivo 13, 14 . We find that blood-derived iNOS-expressing 
64
IL-33 is expressed in barrier tissues in the periphery, including the lung, gut, and skin,
65
where it serves as a sentinel for barrier tissue disruption and is best known for its role in promoting 66 type 2 immune responses during asthma, allergy, and helminth infection [19] [20] [21] 23 . Because this 67 nuclear protein does not contain a secretory signal peptide and does not require processing to be 68 active, it is proposed to be released upon necrotic cell death 19, 21, 24 . Following its release, 69 acts on a heterodimer of the IL-1 receptor accessory protein (IL-1RacP) and its cognate receptor 70 ST2 to initiate classical MyD88-NF-kB signaling which upregulates expression of chemokines and 71 cytokines 20, 21 . In the periphery, IL-33 can signal on a gamut of ST2-expressing cells of 72 hematopoietic origin; those most commonly studied are type 2 innate lymphoid cells (ILC2s), mast 73 cells, and regulatory T cells 20, 21, 25 . Figure 3A ). Blood-derived macrophages were not only present in the brain during 180 infection ( Figure 3B ), but also clustered with high fidelity around replicating parasite ( Figure S3A 
212
( Figure 3I ). These results are consistent with our hypothesis that IL-33 acts directly on astrocytes
213
to induce CCL2 expression and recruit monocyte-derived myeloid cells to the brain.
215
IL-33-ST2 signaling is required for engrafted myeloid cell-derived iNOS expression 216 217
We next probed further into the blood-derived myeloid compartment to assess the anti- 
251
which may provide less opportunity for local CD4 + T cell activation ( Figure 5D ). Importantly, T cell 
307
We have established that IL-33 acts on a radio-resistant responder to recruit immune cells 
324
innate lymphoid cells and alternatively activated macrophages [19] [20] [21] 25 . But the definition of IL-33 325 signaling is broadening; IL-33 now has described roles for inducing a Th1-skewed immune 326 response 60, 61 , and roles in tissue homeostasis 25 . Our work furthers the idea that the outcome of 327 IL-33 signaling is highly dependent on the inflammatory environment. We find that IL-33 plays a 328 role in potentiating the type 1-skewed response necessary for controlling T. gondii in the brain.
329
We demonstrate that IL-33 is required for myeloid cell-derived nitric oxide production in 
